RedPath Integrated Pathology, Inc. Announces Publication Of Study In Endoscopy Showing The Accuracy Of Pathfindertg® In Managing Pancreatic Cysts

PITTSBURGH--(BUSINESS WIRE)--RedPath Integrated Pathology, Inc., a leader in molecular diagnostics, announced that results from The National Pancreatic Cyst Registry, a multicenter clinical study, were published online in Endoscopy. The manuscript, titled, “Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts,” can be accessed at https://www.thieme-connect.de/products/ejournals/html/10.1055/s-0034-1390742.

Help employers find you! Check out all the jobs and post your resume.